Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2008

Conditions
Bacterial InfectionsEye InfectionsCataract Extraction
Interventions
DRUG

AzaSite Eye Drops

One drop two times a day for two days and once a day for the next five days.

DRUG

Vigamox Eye Drops

One drop three times a day for seven days

Trial Locations (13)

11563

Ophthalmic Consultants of Long Island, Rockville Centre

18704

Eye Care Specialists, Kingston

29464

Medical University of South Carolina, Charleston

Glaucoma Consultants and Center for Eye Research, Mt. Pleasant

30339

Coastal Research Associates, LLC, Atlanta

32405

Eye Center of North Florida, Panama City

33176

Center for Excellence in Eye Care, Miami

40207

Kentuckiana Institute for Eye Research, Louisville

63131

Ophthalmology Associates, St Louis

72205

Eye Care Arkansas, Little Rock

79904

Corona Research Consultants, El Paso

85032

Cornea Consultants of Arizone, Phoenix

91345

North Valley Eye Medical Group, Mission Hills

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00575380 - Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery | Biotech Hunter | Biotech Hunter